JPS6349099A - Production of optically active 3-chloro-4-hydroxy-2-cyclopentenone - Google Patents
Production of optically active 3-chloro-4-hydroxy-2-cyclopentenoneInfo
- Publication number
- JPS6349099A JPS6349099A JP19093486A JP19093486A JPS6349099A JP S6349099 A JPS6349099 A JP S6349099A JP 19093486 A JP19093486 A JP 19093486A JP 19093486 A JP19093486 A JP 19093486A JP S6349099 A JPS6349099 A JP S6349099A
- Authority
- JP
- Japan
- Prior art keywords
- chloro
- formula
- hydroxy
- optically active
- cyclobentenone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- WIGMGPJFSYTGDL-UHFFFAOYSA-N 3-chloro-4-hydroxycyclopent-2-en-1-one Chemical compound OC1CC(=O)C=C1Cl WIGMGPJFSYTGDL-UHFFFAOYSA-N 0.000 title abstract 4
- 108090000790 Enzymes Proteins 0.000 claims abstract description 18
- 102000004190 Enzymes Human genes 0.000 claims abstract description 18
- 244000005700 microbiome Species 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- 238000006460 hydrolysis reaction Methods 0.000 claims description 10
- 230000007062 hydrolysis Effects 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- WOPKYMRPOKFYNI-UHFFFAOYSA-N 2-hydroxycyclopent-2-en-1-one Chemical compound OC1=CCCC1=O WOPKYMRPOKFYNI-UHFFFAOYSA-N 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 17
- 238000006243 chemical reaction Methods 0.000 abstract description 13
- 230000003287 optical effect Effects 0.000 abstract description 9
- 150000003208 punaglandins Chemical class 0.000 abstract description 9
- 108090000371 Esterases Proteins 0.000 abstract description 8
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 6
- 239000003960 organic solvent Substances 0.000 abstract description 6
- 239000007853 buffer solution Substances 0.000 abstract description 4
- 108090000604 Hydrolases Proteins 0.000 abstract description 3
- 239000012044 organic layer Substances 0.000 abstract description 3
- 238000004440 column chromatography Methods 0.000 abstract description 2
- VZFDTHXGWAPDKE-UHFFFAOYSA-N (5-oxocyclopenten-1-yl) acetate Chemical compound CC(=O)OC1=CCCC1=O VZFDTHXGWAPDKE-UHFFFAOYSA-N 0.000 abstract 1
- 241000282898 Sus scrofa Species 0.000 abstract 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 abstract 1
- 229960004373 acetylcholine Drugs 0.000 abstract 1
- 230000002440 hepatic effect Effects 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 150000002148 esters Chemical class 0.000 description 15
- 229940088598 enzyme Drugs 0.000 description 14
- 238000000034 method Methods 0.000 description 12
- 238000003756 stirring Methods 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108010022752 Acetylcholinesterase Proteins 0.000 description 2
- 102000012440 Acetylcholinesterase Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- -1 acetyl halide Chemical class 0.000 description 2
- 229940022698 acetylcholinesterase Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000588881 Chromobacterium Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000159512 Geotrichum Species 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 101100096342 Mus musculus Spdef gene Proteins 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000179532 [Candida] cylindracea Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 1
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010575 fractional recrystallization Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 125000001244 punaglandin group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は光学活性な3−クロロ−4−ヒドロキシ−2−
シクロベンテノンの製造法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides optically active 3-chloro-4-hydroxy-2-
This invention relates to a method for producing cyclobentenone.
光学活性な3−クロロ−4−ヒドロキシ−2−シクロベ
ンテノンは、強い筋細胞増殖抑制効果を示す(L 12
10i細胞に対し、I Cs。=0.02〜0.06μ
g / cc)プナグランジン(8)の重要な合成中間
体である。Optically active 3-chloro-4-hydroxy-2-cyclobentenone exhibits a strong muscle cell proliferation inhibitory effect (L 12
ICs for 10i cells. =0.02~0.06μ
g/cc) is an important synthetic intermediate of punaglandin (8).
プナグランジンの合成法は、最近いくつか報告さ九てい
るが、たとえば日本化学会第52春季年会(1986)
、講演予稿集II 1072頁に於て、光学活性な(4
R)−3−クロロ−4−tcrt−ブチルジメチルシリ
ルオキシ−2−シクロベンテノン(1)に、ω側鎖、α
側鎖を順次結合し、プナグランジン(8)を得ている。Several synthetic methods for punaglandin have been reported recently, including the 52nd Spring Annual Meeting of the Chemical Society of Japan (1986).
, Lecture Proceedings II, page 1072, optically active (4
R)-3-chloro-4-tcrt-butyldimethylsilyloxy-2-cyclobentenone (1) has an ω side chain, α
Punaglandin (8) was obtained by sequentially linking the side chains.
(スキーム1) プナグランジン(8)の8位、12位
の不斉は、化合物(1)の4位の不斉より誘導されてい
る。化合物(1)は、たとえば、J、 CheIl、S
oc、 Chem、Comm−、1979]、21に記
載されている方法(スキーム2)、により容易に、(4
R)−3−’クロロー4−ヒドロキシー2−シクロベン
テノン(1)より合成出来る。(Scheme 1) The asymmetry at the 8- and 12-positions of punaglandin (8) is derived from the asymmetry at the 4-position of compound (1). Compound (1) is, for example, J, CheIl, S
oc, Chem, Comm-, 1979], 21 (Scheme 2).
R)-3-' It can be synthesized from chloro-4-hydroxy-2-cyclobentenone (1).
この様に、プナグランジン(8)の合成に於て光学活性
な3−クロロ−4−ヒドロキシ−2−シクロベンテノン
(1)は極めて重要な合成中間体といえる。Thus, optically active 3-chloro-4-hydroxy-2-cyclobentenone (1) can be said to be an extremely important synthetic intermediate in the synthesis of punaglandin (8).
天然型プナグランジン合成上、特に望ましいのは、(4
R)−3−クロロ−4−ヒドロキシ−2−シクロベンテ
ノン[(4R)−11であるが、(4S ) −3−ク
ロロ−4−ヒドロキシ−2−シクロベンテノン[(4S
)−11もブナグランジンのアナログ合成、プロスタグ
ランジンの合成において有用である。Particularly desirable for the synthesis of natural punaglandin is (4
R)-3-chloro-4-hydroxy-2-cyclobentenone [(4R)-11, but (4S)-3-chloro-4-hydroxy-2-cyclobentenone [(4S
)-11 is also useful in bunaglandin analog synthesis and prostaglandin synthesis.
従来、光学活性な3−クロロ−4−ヒドロキシ−2−シ
クロベンテノンの合成法としては、J、 Chew、
Soc、Chem、 Coma、、 1979121に
記載のスキーム2に示す方法が知られている。Conventionally, as a method for synthesizing optically active 3-chloro-4-hydroxy-2-cyclobentenone, J. Chew,
A method shown in Scheme 2 described in Soc, Chem, Coma, 1979121 is known.
すなわち、ラセミ体の3.3.5−トリクロロ−1,4
−ジヒドロキシシクロベント−1−カルボン酸(9)を
ブルシンの塩とし、この塩の分別再結晶によって(IS
、4S)−3,5,5−トリクロロ−1,4−ジヒドロ
キシシクロベント−1−カルボン酸(11)を得、これ
より2工程にて(4R)−3−クロロ−4−ヒドロキシ
−2−シクロベンテノンとしている。しかしながら、こ
の方法はプルシンという高価な試薬を必要とし、又、分
別再結晶という繁雑な繰作を必要とする。That is, racemic 3.3.5-trichloro-1,4
-Dihydroxycyclobent-1-carboxylic acid (9) was converted into a salt of brucine, and this salt was fractionally recrystallized (IS
, 4S)-3,5,5-trichloro-1,4-dihydroxycyclobent-1-carboxylic acid (11) was obtained, from which (4R)-3-chloro-4-hydroxy-2- It is called cyclobentenone. However, this method requires an expensive reagent called purusin, and also requires a complicated process of fractional recrystallization.
ハロゲンを含まない、光学活性な4−ヒドロキシ−2−
シクロベンテノンの製造法としては、光学活性なシクロ
プロパンカルボン酸とdl−ヒトaキシ−2−シクロベ
ンテノンのエステルである、式、
(式中、Rは水素原子、アルキル基、アルケニル基を表
わし、*は光学活性中心を表わす、)で表わされる化合
物を、酵素又は、微生物を用いて不斉加水分解する方法
がある。(特開昭6O−22563119) 又、ス
キーム3に示される方法により2位が置換された光学活
性な4−ヒドロキシ−2−シクロベンテノンの製造法も
知られている。Halogen-free, optically active 4-hydroxy-2-
The method for producing cyclobentenone is an ester of optically active cyclopropanecarboxylic acid and dl-hydroxy-2-cyclobentenone. There is a method of asymmetrically hydrolyzing a compound represented by the following formula (* represents an optically active center) using an enzyme or a microorganism. (JP-A-6O-22563119) A method for producing optically active 4-hydroxy-2-cyclobentenone substituted at the 2-position by the method shown in Scheme 3 is also known.
Tetrahedron、 32.1713 (197
6)、には、dl−4−アセトキシ−2−シクロベンテ
ノンをWheatgorm Lipaseにより加水分
解する方法が記載されているが、得られた4−ヒドロキ
シ−2−シクロベンテノンの光学純度については全く記
載が無い。Tetrahedron, 32.1713 (197
6) describes a method of hydrolyzing dl-4-acetoxy-2-cyclobentenone using Wheatgorm Lipase, but there is no information regarding the optical purity of the obtained 4-hydroxy-2-cyclobentenone. There is no description.
この様に、今まで、分子内にハロゲンを含んスキーム3
日本化学会 第52春季年会講演予講集 II 15
07 (1986)○ 0
だ4−アシルオキシ−2−シクロベンテノンを酵素又は
、微生物を使い、光学純度良く、好収率で不斉加水分解
を行った、という報告は無い。In this way, until now, Scheme 3 containing halogen in the molecule
Chemical Society of Japan 52nd Spring Annual Meeting Lecture Preliminary Collection II 15
07 (1986) ○ 0 There are no reports of asymmetric hydrolysis of 4-acyloxy-2-cyclobentenone using enzymes or microorganisms with good optical purity and good yield.
本発明者らは、プナグランジンの有用な合成中間体であ
る、光学活性な3−クロロ−4−ヒドロキシ−2−シク
ロベンテノンを安価に、工業的に製造し得る方法につい
て検討の結果、本発明に至った。すなわち、式、
で表わされるエステルを、酵素又は微生物を用いいて不
斉加水分解し、光学活性な3−クロロ−4−ヒドロキシ
−2−シクロベンテノンを製造する方法であり、又、上
記の不斉加水分解の結果、残った基質である、式、
(式中、本は光学活性中心を表わす。)で表わされる、
光学活性なエステルを、酵素又は、微生物を用いて加水
分解して、光学活性な3−クロロ−4−ヒドロキシ−2
〜シクロベンテノン(1)を製造する方法である。The present inventors investigated a method for industrially producing optically active 3-chloro-4-hydroxy-2-cyclobentenone, which is a useful synthetic intermediate for punaglandin, and found that the present invention reached. That is, it is a method for producing optically active 3-chloro-4-hydroxy-2-cyclobentenone by asymmetrically hydrolyzing an ester represented by the formula using enzymes or microorganisms, and also for producing optically active 3-chloro-4-hydroxy-2-cyclobentenone. As a result of asymmetric hydrolysis, the remaining substrate is represented by the formula, (wherein the book represents the optically active center),
Optically active ester is hydrolyzed using enzymes or microorganisms to produce optically active 3-chloro-4-hydroxy-2
-A method for producing cyclobentenone (1).
本発明において原料となるエステル(n)は既知の方法
で合成した3−クロロ−4−ヒドロキシ−2−シクロベ
ンテノンを、無水酢酸、又は塩化アセチル等のハロゲン
化アセチルと、ピリジン、トリエチルアミンなどの塩基
の存在下、塩化メチレン、テトラヒドロフラン、ベンゼ
ンなどの溶媒中、又は無溶媒にて反応させることにより
、収率良く得ることができる。In the present invention, the raw material ester (n) is obtained by combining 3-chloro-4-hydroxy-2-cyclobentenone synthesized by a known method with acetic anhydride or acetyl halide such as acetyl chloride, and pyridine, triethylamine, etc. It can be obtained in good yield by reacting in the presence of a base in a solvent such as methylene chloride, tetrahydrofuran, or benzene, or without a solvent.
エステル(II)の不斉加水分力Jよ、該エステルのど
ちらか一方の光学活性体を加水分解する能力を有する酵
素又は、微生物を用いて行われる。The asymmetric hydrolysis of ester (II) is carried out using an enzyme or microorganism capable of hydrolyzing either optically active form of the ester.
不斉加水分解酵素としては、例えば、肝臓エステラーゼ
、すい臓エステラーゼ、アセチルコリンエステラーゼ等
の動物エステラーゼ、あるいは植物エステラーゼが挙げ
られ、さらには、以下に示す各屈に居する微生物や地衣
類、藻類などの微生物又は、これらより得られる加水分
解酵素が挙げられる。Examples of asymmetric hydrolases include animal esterases such as liver esterase, pancreatic esterase, and acetylcholinesterase, and plant esterases, and furthermore, microorganisms such as the following microorganisms, lichens, and algae that live in various organisms. Alternatively, hydrolytic enzymes obtained from these may be mentioned.
Rhodortoula+Trichoderma+C
andida、 tlanse−nula+Pseud
omonas、 Bacillus+Achromob
acter−Nocardia+Chromobact
erium= Flavobacterium。Rhodortoula+Trichoderma+C
andida, trans-nula+Pseud
omonas, Bacillus+Achromob
acter-Nocardia+Chromobact
erium = Flavobacterium.
RhizopusSMucor−Aspergillu
s−A1kalj4cnes。Rhizopus SMucor-Aspergillus
s-A1kalj4cnes.
Torulopsis−Corynebacteriu
m−Endomyces。Torulopsis-Corynebacterium
m-Endomyces.
Saccharormyces−Arthrobact
er+He1minthospo−rium+Brev
ibacterium1ε5cherichia+C1
troba−cter、 Absidia−Micro
coccus、 Pediococcus。Saccharormyces-Arthrobact
er+He1minthospo-rium+Brev
ibacterium1ε5cherichia+C1
troba-cter, Absidia-Micro
coccus, Pediococcus.
Klebsie11a+Geotrichum+Lac
tobacillus−Cry−ptococcus+
Pichia%Aureobasidiun++Aet
ino−mueor、 Enterobacter、M
icrobacterium、 Pen1ci−11i
urn、Schizophyllium。Klebsie11a+Geotrichum+Lac
tobacillus-Cry-ptococcus+
Pichia%Aureobasidiun++Aet
ino-mueor, Enterobacter, M
icrobacterium, Pen1ci-11i
urn, Schizophylium.
本発明において、用いられる加水分解vf素の使用形態
としては、精嬰酵素、粗酵素、酵素含有物、微生物培養
液、培養物、菌体、培養ろ液又は、それらを処理した物
など必要に応じ、種々の形態で用いる事ができる。In the present invention, the form of use of the hydrolyzed VF element used includes sperm enzyme, crude enzyme, enzyme-containing material, microorganism culture fluid, culture, bacterial cells, culture filtrate, or processed products thereof. It can be used in various forms depending on the situation.
又、樹脂等に固定化して、固定化酵素、固定化菌体とし
て用いる事ができる。Furthermore, it can be immobilized on a resin or the like and used as an immobilized enzyme or an immobilized bacterial cell.
不斉加水分解反応は、エステル(■)、又は(111)
と上記加水分解酵素、又1ま微生物、好ましくはブタ肝
臓エステラーゼ、アセチルコリンエステラーゼ、Pse
udomonas山来の精製又は粗酵素由来Candi
da cylindracea由来の精製又は粗酵素を
通常、緩衝液中又は、有機溶媒と緩衝液の混合液中、必
要なら界面活性剤を加えて激しく攪はんする事により行
なわれる。In the asymmetric hydrolysis reaction, ester (■) or (111)
and the above hydrolase, or a microorganism, preferably pig liver esterase, acetylcholinesterase, Pse
Candi derived from purified or crude enzyme of udomonas yamaki
The purification or crude enzyme derived from D. da cylindracea is usually carried out in a buffer solution or a mixture of an organic solvent and a buffer solution, with the addition of a surfactant if necessary, and vigorous stirring.
有機溶媒と緩衝液の混合液を用いる場合に使用される有
機溶媒は1通常水溶性の溶媒、例えばメタノール、エタ
ノール等のアルコール類、アセトン、メチルエチルケト
ン等のケトン類、アセトニトリル、プロピオニトリル等
のニトリル類などが使用出来る。When using a mixture of an organic solvent and a buffer, the organic solvent used is usually a water-soluble solvent, such as alcohols such as methanol and ethanol, ketones such as acetone and methyl ethyl ketone, and nitriles such as acetonitrile and propionitrile. etc. can be used.
緩衝液は、リン酸ナトリウム、リン酸カリウム、クエン
酸ナトリウム等の、通常用いられる緩衝液が使用出来る
。緩衝液の代わりに、精X水を用い、PHの調整はPH
スタットで行うことも出来る。As the buffer, commonly used buffers such as sodium phosphate, potassium phosphate, sodium citrate, etc. can be used. Use purified X water instead of a buffer solution, and adjust the pH by adjusting the pH
It can also be done with a stat.
反応温度は一20〜+40’C1反応時間は2〜50時
間が好ましいが、これに限定されるものではない。The reaction temperature is preferably -20 to +40'C1 and the reaction time is preferably 2 to 50 hours, but is not limited thereto.
反応終了後、加水分解反応液を必要に応じて濾過し、メ
チルイソブチルケトン、酢酸エチル、ジエチルエーテル
、ジクロロメタン等の有機溶媒により抽出し、有機層を
濃縮、カラムクロマト精製を行うことにより、目的とす
る光学活性な3−クロロ−4−ヒドロキシ−2−シクロ
ベンテノン(I)と、未加水分解物である、光学活性な
4−アセトキシ−3−クロロ−2−シクロベンテノン(
Tll)を得る。After the reaction is completed, the hydrolysis reaction solution is filtered as necessary, extracted with an organic solvent such as methyl isobutyl ketone, ethyl acetate, diethyl ether, dichloromethane, etc., and the organic layer is concentrated and purified by column chromatography to obtain the desired product. optically active 3-chloro-4-hydroxy-2-cyclobentenone (I), and optically active 4-acetoxy-3-chloro-2-cyclobentenone (I), which is an unhydrolyzed product.
Tll) is obtained.
分離された光学活性なエステル(]■)は、これを加水
分解することにより、先に得た光学活性なアルコール(
1)とは逆の配位を有する光学活性なアルコール(1)
をえることができる。The separated optically active ester (]■) is hydrolyzed to form the previously obtained optically active alcohol (
Optically active alcohol (1) with the opposite coordination to 1)
You can get
光学活性なエステル(III)のアルコール(1)への
加水分解反応は、前述のエステル(II)をアルコール
(I)へ不斉加水分解を行ったと同様の方法で行う事が
できる。The hydrolysis reaction of optically active ester (III) to alcohol (1) can be carried out in the same manner as the above-mentioned asymmetric hydrolysis of ester (II) to alcohol (I).
本発明の方法によれば、エステル(TI)の不斉加水分
解により一方の光学活性な3−クロロ−4−ヒドロキシ
−2−シクロベンテノン(I)が得られ、又、同時に得
られた未加水分解物である光学活性なエステル(In
)を加水分解することにより、先に得たものと逆の配位
をもつ光学活性な3−クロロ−4−ヒドロキシ−2−シ
クロベンテノンを得る。According to the method of the present invention, one optically active 3-chloro-4-hydroxy-2-cyclobentenone (I) is obtained by asymmetric hydrolysis of the ester (TI), and the unobtained compound simultaneously obtained. Optically active ester (In
) to obtain optically active 3-chloro-4-hydroxy-2-cyclobentenone having the opposite coordination to that obtained previously.
実施例記載の光学活性な3−クロロ−4−ヒドロキシ−
2−シクロベンテノン(1)の光学純度の決定はスキー
ム4に示さ九る方法により、アセタールケトン(rV)
に導き、高速液体クロマトグラフィーにより、そのジア
ステレオマー比を求めることにより行った。Optically active 3-chloro-4-hydroxy- as described in Examples
The optical purity of 2-cyclobentenone (1) was determined by the method shown in Scheme 4.
The diastereomer ratio was determined by high performance liquid chromatography.
(I) (IV)(式中、本
は光学活性中心を表わす、)次に具体的に実施例を挙げ
て説明するが、本発明は、こわらのみに限定されるもの
ではない。(I) (IV) (In the formula, this represents an optically active center.) Next, examples will be specifically described, but the present invention is not limited to only stiff particles.
参考例 1
4−アセトキシ−3−クロロ−2−シクロベンテノン
dl−3−クロロ−4−ヒドロキシ−2−シクロベンテ
ノン(J、 Chem、 Soc、y胆η121に記載
の方法に準拠して合成) 6.8g を−5℃に冷却
し、ピリジン100m12をδ4下する。N、N−ジメ
チルアミノ−4−ピリジン0.6gを加えた後、無水酢
酸15.0mMを一5℃にて滴下する。Reference example 1 4-acetoxy-3-chloro-2-cyclobentenone dl-3-chloro-4-hydroxy-2-cyclobentenone (synthesized according to the method described in J, Chem, Soc, y bile η121 ) 6.8 g was cooled to -5°C, and 100 m12 of pyridine was reduced by δ4. After adding 0.6 g of N,N-dimethylamino-4-pyridine, 15.0 mM of acetic anhydride was added dropwise at -5°C.
滴下後、−5℃/4時間攪拌し、反応液を冷水中にあけ
、塩化メチレンにて抽出する。有@層をIN−塩酸、食
塩水、重曹水、食塩水、にて順次洗浄し、無水硫酸ナト
リウ11て・4燥後、濃縮し、シリカゲルカラムクロマ
ト精mを行い、di −4−アセトキシ−3−クロロ−
2−シクロベンテノン6.2gを得た。After the dropwise addition, the mixture was stirred at -5°C for 4 hours, and the reaction solution was poured into cold water and extracted with methylene chloride. The present layer was washed sequentially with IN-hydrochloric acid, brine, sodium bicarbonate solution, and brine, dried with anhydrous sodium sulfate, concentrated, purified by silica gel column chromatography, and purified with di-4-acetoxy- 3-chloro-
6.2 g of 2-cyclobentenone was obtained.
”)I−NMR(100MHz)δ(CDCI、) :
6.40 (1,1(、d)。”) I-NMR (100MHz) δ (CDCI, ):
6.40 (1,1(,d).
5.88 (ill、 ddd)、 3.OII (I
H,dd)、 2.46 (IH。5.88 (ill, ddd), 3. OII (I
H, dd), 2.46 (IH.
dd)、 2.18 (311,s)
I R(neat) −y am−1: 1750.
1730.1600゜1435.1405. 1375
゜
参考例 2
4−アセトキシ−3−クロロ−2−シクロベンテノン
dl−3−クロロ−4−ヒドロキシ−2〜シクロベンテ
ノン10.0g、塩化メチレン150威を0℃に冷却し
、トリエチルアミン20.Rを滴下する。dd), 2.18 (311,s) I R(neat) -y am-1: 1750.
1730.1600°1435.1405. 1375
゜Reference Example 2 4-acetoxy-3-chloro-2-cyclobentenone 10.0 g of dl-3-chloro-4-hydroxy-2-cyclobentenone and 150 g of methylene chloride were cooled to 0°C, and 20.0 g of triethylamine was added. Add R dropwise.
N、N−ジメチルアミノ−4−ピリジン0.1gを添加
後、塩化アセチル15 、0 mQを滴下する。After adding 0.1 g of N,N-dimethylamino-4-pyridine, 15.0 mQ of acetyl chloride is added dropwise.
0 ’C/ 2時間攪拌後、参考例]と同様に後処理、
精製を行い、di−4−アセトキシル3−クロロ−2−
シクロベンテノン9.7Kを得た。After stirring at 0'C/2 hours, post-treatment was carried out in the same manner as in Reference Example].
Purification was performed to obtain di-4-acetoxyl 3-chloro-2-
9.7K of cyclobentenone was obtained.
実施例1
di−4−アセトキシ−3−クロロ−2−シクロベンテ
ノン3.9gにPl+ 7.0リン酸緩衝液300mQ
及びブタ肝臓エステラーゼ(シグマ社製) 0.2mQ
を加え、37°Cにて5時間、激しく攪拌する。Example 1 3.9 g of di-4-acetoxy-3-chloro-2-cyclobentenone and 300 mQ of Pl+ 7.0 phosphate buffer
and pig liver esterase (manufactured by Sigma) 0.2 mQ
and stir vigorously at 37°C for 5 hours.
反応液を塩化メチレン50m9にて5回抽出する。The reaction solution was extracted five times with 50 m9 of methylene chloride.
有機層を無水硫酸ナトリウムにて乾燥、濃縮、シリカゲ
ルカラムクロマト精製(酢酸エチル/n−ヘキサン=
i / 3 )を行い、 (4R)〜3−クロロー4−
ヒドロキシー2−シクロベンテノン1.2g ([aE
= +32.6°(c ] 、 CHCl、)、光学純
度 90%ee) と(4S)−4−アセトキシ−3
−クロロ−2−シクロベンテノン2.2g([α〕o=
+10.0°(c 1 、 CHCl3))を得た6実
施例2
実施例1で得た(4.3)−4−アセトキシ−3−クロ
ロ−2−シクロベンテノン2.2gに、ト’J トンX
−1000,3g、 PH7,OU:/酸8%液110
−及びCandida cylindraceaの粗酵
素]00mgを加え、20℃720時間徴しく攪拌する
1反応液を実施例1と同様に後処理、精製を行い、(4
S)−3−クロロ−4−ヒドロキシ−2−シクロベンテ
ノン1.4g ([α$= −27,5゜(c 1.
CHCl、)、 光学純度75%ee)を得た。The organic layer was dried over anhydrous sodium sulfate, concentrated, and purified by silica gel column chromatography (ethyl acetate/n-hexane =
i/3) and (4R)~3-chloro4-
Hydroxy-2-cyclobentenone 1.2g ([aE
= +32.6°(c], CHCl,), optical purity 90%ee) and (4S)-4-acetoxy-3
-chloro-2-cyclobentenone 2.2 g ([α]o=
+10.0°(c 1 , CHCl3)) Example 2 To 2.2 g of (4.3)-4-acetoxy-3-chloro-2-cyclobentenone obtained in Example 1, J ton X
-1000,3g, PH7,OU:/8% acid solution 110
- and Candida cylindracea crude enzyme] and stirred vigorously for 720 hours at 20°C. The reaction solution was post-treated and purified in the same manner as in Example 1.
S)-3-chloro-4-hydroxy-2-cyclobentenone 1.4 g ([α$= -27,5° (c 1.
CHCl, ), optical purity 75%ee) was obtained.
実施例3
dl−4−アセトキシ−3−クロロ−2−シクロベンテ
ノン2.0gに、PH7,0リン酸緩衝液150m1l
、トリトンX −1003001Eを加え、攪拌する。Example 3 To 2.0 g of dl-4-acetoxy-3-chloro-2-cyclobentenone, 150 ml of PH7.0 phosphate buffer was added.
, Triton X-1003001E and stir.
・Candida cylinclracea由来の
粗酵素1100IIIを加え7℃で7時間激しく攪拌す
る。- Add crude enzyme 1100III derived from Candida cylinclracea and stir vigorously at 7°C for 7 hours.
反応液を濾過し、炉液を実施例1と同様に後処理、精製
を行い、(4R)−3−クロロ−4−ヒドロキシ−2−
シクロベンテノン570mg([a H:+36.9°
(c O,5,CHCl、)+ 光学純L97%ee
)と(4S)−4−アセトキシ−3−クロロ−2−シク
ロベンテノン850mg ([α勇:+12.5° (
c 1.0. CllCl、 )) をnだ。The reaction solution was filtered, and the reaction solution was post-treated and purified in the same manner as in Example 1 to obtain (4R)-3-chloro-4-hydroxy-2-
Cyclobentenone 570 mg ([a H: +36.9°
(c O, 5, CHCl,) + optically pure L97%ee
) and (4S)-4-acetoxy-3-chloro-2-cyclobentenone 850mg ([αY:+12.5° (
c 1.0. CllCl, )) is n.
実施例4
実施例3で得た<43)−4−アセトキシ−3−クロロ
−2−シクロベンテノン830mgにPl+7.0のリ
ン酸緩衝液200+nQ 、 Aspcrgillus
由来の粗酵素40−を加え、30℃で18時間激しく攪
拌する2反応液を濾過し、′05液を実施例1と同様に
、後処理、精製を行い、(4S)−3−クロロ−4−ヒ
ドロキシル2−シクロベンテノン530mg ([α詰
=−32,8°(c O,5,CHCl5 )。Example 4 830 mg of <43)-4-acetoxy-3-chloro-2-cyclobentenone obtained in Example 3 was mixed with 200+nQ of phosphate buffer of Pl+7.0, Aspcrgillus
Add the crude enzyme 40-derived and stir vigorously at 30°C for 18 hours.The reaction mixture was filtered, and the '05 solution was post-treated and purified in the same manner as in Example 1 to obtain (4S)-3-chloro- 530 mg of 4-hydroxyl 2-cyclobentenone ([α packed = -32,8° (cO,5, CHCl5).
光学純度92%ee)を得た。An optical purity of 92%ee) was obtained.
実施例5
dl−4−アセトキシ−3−クロロ−2−シクロベンテ
ノン2.1gにメタノール2oシ、水8offliIを
加え一5℃とする。 Pseudomonas由来の粗
間S 110+ngを加え、P )Iスタットにより反
応液のPHを6.5〜7.5の範囲に調整しながら、−
5℃で15時間激しく攪拌する。Example 5 To 2.1 g of dl-4-acetoxy-3-chloro-2-cyclobentenone were added 20 g of methanol and 8 offli1 of water, and the mixture was heated to -5°C. 110+ng of crude S derived from Pseudomonas was added, and while adjusting the pH of the reaction solution to a range of 6.5 to 7.5 using a P)I stat, -
Stir vigorously for 15 hours at 5°C.
反応液をが過し、が液を実施例1と同様に後処理、精製
を行い、(4R)−3−クロロ−4=ヒドロキシ−2−
シクロベンテノン560B(CaM= +32.2°(
c O,9,CHCl、)、光学純度93%ee)と(
4S)−4−アセトキシ−3−クロロ−2−シクロベン
テノン790mg ([α腰=+12.6° (c 0
、9 、 CIICL ) を得た。The reaction solution was filtered, and the solution was post-treated and purified in the same manner as in Example 1 to obtain (4R)-3-chloro-4=hydroxy-2-
Cyclobentenone 560B (CaM= +32.2°(
cO,9,CHCl,), optical purity 93%ee) and (
4S)-4-acetoxy-3-chloro-2-cyclobentenone 790 mg ([α waist=+12.6° (c 0
, 9, CIICL) were obtained.
実施例6
dl−アセトキシ−3−クロロ−2−シクロペンテン2
.5gにアセトンSod、水200mQを加え7℃に冷
却する。 Psaudomonas由来のm u m
3200mgを添加しPHスタットにて反応液のPHを
6.5〜7.5にF151しながら7℃で7時間激しく
攪拌する。反応液を濾過し、決液を実施例1と同様に後
処理、精製を行い、(4R)−3−クロロ−4−ヒドロ
キシ−2−シクロベンテノン(CaM= +33.9°
(c 1. CllCl、)、光学純度97.0%ee
)と(4S)−4−アセトキシ−3−りoo−2−シク
ロペンテ/ ’/ ([a@= +7.9’(c 1.
0. CIICL ))を得た。Example 6 dl-acetoxy-3-chloro-2-cyclopentene 2
.. Add acetone Sod and 200 mQ of water to 5 g and cool to 7°C. Mu m derived from Psaudomonas
After adding 3200 mg, the pH of the reaction solution was adjusted to 6.5 to 7.5 using a PH stat, and the mixture was vigorously stirred at 7° C. for 7 hours at F151. The reaction solution was filtered, and the final solution was post-treated and purified in the same manner as in Example 1 to obtain (4R)-3-chloro-4-hydroxy-2-cyclobentenone (CaM = +33.9°
(c 1. CllCl,), optical purity 97.0%ee
) and (4S)-4-acetoxy-3-rioo-2-cyclopente/'/ ([a@= +7.9'(c 1.
0. CIICL)) was obtained.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19093486A JPS6349099A (en) | 1986-08-14 | 1986-08-14 | Production of optically active 3-chloro-4-hydroxy-2-cyclopentenone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19093486A JPS6349099A (en) | 1986-08-14 | 1986-08-14 | Production of optically active 3-chloro-4-hydroxy-2-cyclopentenone |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6349099A true JPS6349099A (en) | 1988-03-01 |
Family
ID=16266115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP19093486A Pending JPS6349099A (en) | 1986-08-14 | 1986-08-14 | Production of optically active 3-chloro-4-hydroxy-2-cyclopentenone |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6349099A (en) |
-
1986
- 1986-08-14 JP JP19093486A patent/JPS6349099A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0501310B1 (en) | Method for optical resolution of corey lactone diols | |
AU670088B2 (en) | Enzymatic process to separate racemic mixtures of delta valerolactones | |
JPH05236992A (en) | Production of optically active 4-amino-3 hydroxycarboxylic acid | |
JPS6349099A (en) | Production of optically active 3-chloro-4-hydroxy-2-cyclopentenone | |
JPH06256278A (en) | Optically active alpha-carbamoylalkanoic acid derivative and its production | |
US5654440A (en) | Method for production of optically active (+)-4,4,4-trifluoro-3-(indole-3-)butyric acid | |
JP3072150B2 (en) | Method for producing optically active [3] (1,1 ') ferrocenophanes | |
JP3010382B2 (en) | Method for producing (R) -2-propoxybenzene derivative | |
US5272069A (en) | Method of producing optically active hydroxyesters | |
JPH01281098A (en) | Production of optically active carboxylic acid and optically active carboxylic acid ester | |
JPH04356195A (en) | Production of azetidinone derivative | |
JP3217301B2 (en) | Method for producing optically active glycidic acid ester and optically active glyceric acid ester | |
JPH05227991A (en) | Production of optically active 3-pyrrolidinol derivative | |
JP3206011B2 (en) | Imide derivative and method for producing the same | |
JPH03254695A (en) | Production of optically active aminopropanediol derivative and its antipode ester | |
JP2518499B2 (en) | Process for producing optically active 4-hydroxy-2-cyclopentenones | |
JPS58190395A (en) | Preparation of optically active cis-imidazolidinedicarboxylic acid derivative | |
JPS63109797A (en) | Production of optically active cyclopentenones | |
JPH02240045A (en) | Method for separating optically active 4-hydroxy-2-cyclopentenones | |
JPH06205686A (en) | Production of optically active 1,4-dihydropyridine compound having selective steric configuration | |
JPH06261787A (en) | Production of optically active beta-amino acid | |
JPH0670784A (en) | Production of optically active 4-cyclopentenones | |
JPH0615486B2 (en) | Process for producing optically active 4-hydroxy-2-cyclopentenones | |
JPH05284986A (en) | Production of optically active 1,4-dihydropyridine compound | |
JPH02250847A (en) | Separation of optical activator mixture |